Company profile
Halberd Corporation
OTC: HALB · Healthcare · Biotechnology
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 33
v0.1 · 5/100 weight · pillars only
↑ listing tenure, market scale · ↓ Piotroski F, Altman-Z
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
—
Employees
3
as of 2026-08-27
Market cap
$438.5k
as of 2026-08-27
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Halberd Corporation’s financial profile?
Halberd Corporation has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
OJsys, Inc.——PPJ Healthcare Enterprises, Inc.——Mosaic ImmunoEngineering Inc.——IM Cannabis Corp.——Southern Home Medical, Inc.——CBD Life Sciences Inc.——Key facts
CEOWilliam A. Hartman
SectorHealthcare
IndustryBiotechnology
HeadquartersJackson Center, PA
ExchangeOTC: HALB
Employees3
IPO date2012-09-25
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.